Welcome to The Visible Embryo
  o
Home-- -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than one million visitors each month.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human. The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.

WHO International Clinical Trials Registry Platform


The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!





Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

 

Pregnancy Timeline by SemestersLungs begin to produce surfactantImmune system beginningHead may position into pelvisFull TermPeriod of rapid brain growthWhite fat begins to be madeHead may position into pelvisWhite fat begins to be madeImmune system beginningBrain convolutions beginBrain convolutions beginFetal liver is producing blood cellsSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresFemale Reproductive SystemEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterSecond TrimesterFirst TrimesterFertilizationDevelopmental Timeline
CLICK ON weeks 0 - 40 and follow along every 2 weeks of fetal development
Google Search artcles published since 2007
 
 

Home | Pregnancy Timeline | News Alerts |News Archive Mar 4, 2015

Epigenetic diagram showing how DNA is altered by Methylation groups.
When many methyl groups (orange dots) concentrate in one area, gene expression is shut down.
If the DNA has few or no methyl groups — the gene is turned on or "expressed" by cell machinery.
Image Credit: Imperial College London, Department of Surgery and Cancer

 






 

 

Epigenome orchestrates embryo development

As the early embryo develops, cells transform into the tissues we need to make and regenerate life. Now, science is finding this process is largely controlled not by our genes, but by the epigenome, the environmental chemical markers that latch onto our DNA and initiate which genes are to be turned on or off.

Studying zebrafish embryos, researchers at Washington University School of Medicine in St. Louis have shown that the epigenome plays a significant part in guiding development in the first 24 hours after fertilization. The research, which appeared Feb. 20 in the journal Nature Communications, deepens our understanding of congenital defects and miscarriage.

The epigenome is a bit like software that interprets the DNA code hard-wired into each of our body's cells. While the DNA hardware is the same in each cell, differences in the epigenome — the software — differentiates brain cells from muscle, skin, eye or heart cells.

Using zebrafish as a model of vertebrate animals, the new study is the first to map changes in the epigenome of whole embryos and follow gene regulation during the earliest moments of development.


"Our study suggests that an underappreciated fraction of the genome is involved in gene regulation.

"Another surprising finding is that many of the important regions of DNA we identified are pretty far from the genes they regulate.

"The field has long been focused on identifying genes that manufacture proteins. We show the epigenome is just as important and is largely uncharted."

Ting Wang PhD, senior author, Principal Investigator, Roadmap Epigenomics Program, Assistant Professor, Department of Genetics, Washington University School of Medicine, St. Louis, Missouri.


Wang is a principal investigator on the Roadmap Epigenomics Program, a national initiative to map the human epigenome. Researchers leading this program recently published large data sets detailing information about human epigenetics.

Wang: "In humans, for ethical reasons, we only look at tissues in childhood and adulthood and describe differences between cell types. But with zebrafish, we can watch developmental processes unfold."


Wang and first author Hyung Joo Lee (a graduate student in Wang's lab) studied zebrafish embryos at five intervals following fertilization, stopping at the 24-hour mark when an embryo starts to develop separate tissues.


At each of these 5 points in time, investigators measured several ways the epigenome regulates gene expression, one of the most important being methyl groups. Methyl groups are organic compounds that attach to the DNA in different locations adding a carbon molecule.

When many methyl groups concentrate in one area, gene expression is shut down and that segment of DNA is packaged away. If the DNA is demethylated — with few or no methyl groups — then the genes are unpackaged by cell machinery and the gene becomes "expressed."

Most studies of DNA methylation have focused on areas close to genes called promoter regions that function like switches to turn gene expression on or off. Wang: "But our data show that only 5 percent of DNA methylation changes happen in conventionally defined promoter regions."


The scientists were surprised to discover 95 percent of methylation change occurs in regions far away from genes or their promoters — in parts of the genome considered noncoding because cell machinery is not nearby to enlist in making a particular protein.


At distant sites, losing methyl groups tended to increase gene expression. And it was seen that a graduated loss of methyl groups increased as stages of development progressed. Using various techniques, researchers correlated the loss of methyl groups in one location with the increase of gene expression in another.


Scientists surmised that noncoding regions function as developmental enhancers.

This concept allowed researchers to statistically predict which noncoding regions of the genome were potentially turning on expression of distant genes.

They verified 20 noncoding regions in zebrafish, thus explaining why 20 enhancer regions promoted developmental genes to become defined tissues, such as the eye or parts of the brain and spinal cord.


Wang: "This study suggests that many diseases may have an epigenetic origin. Even if there is nothing wrong with the protein coding genes themselves, there are lots of different regulatory changes that could mess up gene expression and lead to disease."

The investigators point out that many developmental problems, whether they result in the loss of the embryo in miscarriage or to later developmental disorders, are not connected to a particular gene.

This study supports the trend of scientists to find more and more noncoding parts of the genome are essential to gene regulation.


"I'm sure there are parts of the genome for which we may never find a function. But when we look deep, we do see very complex regulatory relationships between noncoding regions and the distant genes they regulate."

Ting Wang PhD


Abstract
DNA methylation undergoes dynamic changes during development and cell differentiation. Recent genome-wide studies discovered that tissue-specific differentially methylated regions (DMRs) often overlap tissue-specific distal cis-regulatory elements. However, developmental DNA methylation dynamics of the majority of the genomic ?CpGs outside gene promoters and CpG islands has not been extensively characterized. Here, we generate and compare comprehensive DNA methylome maps of zebrafish developing embryos. From these maps, we identify thousands of developmental stage-specific DMRs (dsDMRs) across zebrafish developmental stages. The dsDMRs contain evolutionarily conserved sequences, are associated with developmental genes and are marked with active enhancer histone posttranslational modifications. Their methylation pattern correlates much stronger than promoter methylation with expression of putative target genes. When tested in vivo using a transgenic zebrafish assay, 20 out of 20 selected candidate dsDMRs exhibit functional enhancer activities. Our data suggest that developmental enhancers are a major target of DNA methylation changes during embryogenesis.

Authors
Lee HJ, Lowdon RF, Maricque B, Zhang B, Stevens M, Li D, Johnson SL, Wang T. Developmental enhancers revealed by extensive DNA methylome maps of zebrafish early embryos. Nature Communications. Feb. 20, 2015.

Roadmap Epigenomics Program, is a national initiative supported by the National Institutes of Health (NIH).

This work is supported by the Washington University McDonnell International Scholars Program; the Kwanjeong Educational Foundation; the National Science Foundation (NSF), grant number DGE-1143954; the National Institute on Drug Abuse's R25 programme DA027995; the March of Dimes Foundation, the American Cancer Society; and the National Institutes of Health (NIH), grant numbers R01GM05698, R01HG007354, R01HG007175 and R01ES024992.

Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.

Return to top of page